Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749670 · ClinicalTrials.gov registry record
Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 45
- Enrollment target
NCT01749670: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT01749670 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01749670 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
There is accumulating evidence that genetic expression plays a role in autism spectrum disorder, but the regulation of such genes is poorly understood. Small RNA particles, called microRNA (miRNA), have the ability to alter gene expression. These particles can be packaged and released from brain cells into the blood. Changes in miRNA may contribute to the patterns observed in autism spectrum disorder. The purpose of this study is to identify small RNA particles that regulate gene expression in autism spectrum disorder. The goal is to identify miRNA expression patterns which may improve our understanding and diagnosis of autism spectrum disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-09 |
What the finished NCT01749670 record still lists
NCT01749670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01749670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01749670 about?
NCT01749670 is a clinical study titled "Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder". There is accumulating evidence that genetic expression plays a role in autism spectrum disorder, but the regulation of such genes is poorly understood. Small RNA particles, called microRNA (miRNA), have the ability to alter gene expression. These particles can be packaged and released from brain cel...
What is the current status of trial NCT01749670?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2013-01. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01749670?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia